Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2hl1 | A3S | Threonine--tRNA ligase | 6.1.1.3 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2hl1 | A3S | Threonine--tRNA ligase | 6.1.1.3 | 1.000 | |
4rrq | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.658 | |
3pd5 | TSB | Threonine--tRNA ligase | 6.1.1.3 | 0.620 | |
2hl2 | SSA | Threonine--tRNA ligase | 6.1.1.3 | 0.597 | |
3pd2 | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.594 | |
3pd3 | A3T | Threonine--tRNA ligase | 6.1.1.3 | 0.573 | |
4rrf | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.569 | |
4rrr | A3T | Threonine--tRNA ligase | 6.1.1.3 | 0.564 | |
3pd4 | A3G | Threonine--tRNA ligase | 6.1.1.3 | 0.563 | |
4rrg | A3T | Threonine--tRNA ligase | 6.1.1.3 | 0.545 | |
2hl0 | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.539 | |
4rrm | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.526 | |
4rrh | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.525 | |
4rra | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.513 | |
4rri | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.513 | |
4rr7 | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.496 | |
4rrb | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.492 | |
4rr8 | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.487 | |
3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.484 | |
4rrd | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.483 | |
4rrl | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.483 | |
4rrc | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.481 | |
1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.475 | |
3q43 | D66 | M1 family aminopeptidase | 3.4.11 | 0.474 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.470 | |
4i9i | 1DY | Tankyrase-1 | 2.4.2.30 | 0.469 | |
5ecc | NAP | Dehydrofolate reductase type I | / | 0.469 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.468 | |
4x5i | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
1r2j | FAD | FkbI | / | 0.467 | |
1syn | F89 | Thymidylate synthase | / | 0.467 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
4y3j | HIC | Endothiapepsin | 3.4.23.22 | 0.467 | |
1ia1 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.466 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.466 | |
1q4x | G24 | Thyroid hormone receptor beta | / | 0.465 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.465 | |
4rr6 | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.465 | |
5iub | CLR | Adenosine receptor A2a | / | 0.465 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.464 | |
3nxx | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
4rrk | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.462 | |
1od1 | 0QS | Endothiapepsin | 3.4.23.22 | 0.461 | |
1dr3 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
2acw | UPG | Glycosyltransferase | / | 0.459 | |
5h8t | RTL | Retinol-binding protein 1 | / | 0.459 | |
1fml | RTL | Retinol dehydratase | / | 0.458 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
3dr1 | C5D | Vitamin D3 receptor A | / | 0.458 | |
4y3z | F41 | Endothiapepsin | 3.4.23.22 | 0.458 | |
1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
4bfp | SWY | Tankyrase-2 | 2.4.2.30 | 0.457 | |
4e4q | RRH | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2ham | C33 | Vitamin D3 receptor | / | 0.456 | |
3pgi | F41 | Endothiapepsin | 3.4.23.22 | 0.456 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.456 | |
1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.455 | |
3v49 | PK0 | Androgen receptor | / | 0.454 | |
4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.454 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.454 | |
1dhi | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.453 | |
4rr9 | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.453 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.452 | |
1ve3 | SAM | Uncharacterized protein | / | 0.452 | |
4xym | COA | Acyl-CoA synthetase (NDP forming) | / | 0.452 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.451 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.451 | |
4fa6 | 0TA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.451 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.451 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.450 | |
4pkl | 1GH | Uncharacterized protein | / | 0.450 | |
5k0s | 0OU | Methionine--tRNA ligase | / | 0.450 | |
1tka | N3T | Transketolase 1 | 2.2.1.1 | 0.449 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.449 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.449 | |
3nhw | ZXZ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.449 | |
4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.449 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1q4u | 4CA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.448 | |
1rb2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.448 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
4rrx | LUR | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.448 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.448 | |
1ay0 | TPP | Transketolase 1 | 2.2.1.1 | 0.447 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
1fwk | ADP | Homoserine kinase | 2.7.1.39 | 0.446 | |
1gpe | FAD | Glucose oxidase | 1.1.3.4 | 0.446 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.446 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
1zpr | CB3 | Thymidylate synthase | / | 0.446 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.446 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.446 | |
4m48 | 21B | Sodium-dependent dopamine transporter | / | 0.446 | |
1dr5 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
2har | OCC | Vitamin D3 receptor | / | 0.445 | |
2has | C3O | Vitamin D3 receptor | / | 0.445 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.445 | |
2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.445 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.445 | |
3q5k | D1U | Heat shock protein 83-1 | / | 0.445 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.445 | |
4ite | TEY | Vitamin D3 receptor | / | 0.445 | |
4li6 | 1XO | Tankyrase-1 | 2.4.2.30 | 0.445 | |
4q0a | 4OA | Vitamin D3 receptor A | / | 0.445 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.445 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.445 | |
1gvv | 0GM | Endothiapepsin | 3.4.23.22 | 0.444 | |
1qiw | DPD | Calmodulin | / | 0.444 | |
1tkc | M6T | Transketolase 1 | 2.2.1.1 | 0.444 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2r8p | T6F | Transketolase 1 | / | 0.444 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.444 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
4zea | IMI | Endothiapepsin | 3.4.23.22 | 0.444 | |
3sn6 | P0G | Beta-2 adrenergic receptor | / | 0.444 | |
1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.443 | |
2ea2 | F77 | Methionine aminopeptidase 2 | / | 0.443 | |
2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.443 | |
2xiz | XIZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.443 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3vru | YS3 | Vitamin D3 receptor | / | 0.443 | |
4m11 | MXM | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.443 | |
4m9a | FDA | Acyl-CoA dehydrogenase | / | 0.443 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1rx8 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.442 | |
2ojg | 19A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
2r8o | T5X | Transketolase 1 | / | 0.442 | |
3hk1 | B64 | Fatty acid-binding protein, adipocyte | / | 0.442 | |
3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.442 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.442 | |
4qys | PLR | Tryptophan synthase beta chain 2 | 4.2.1.20 | 0.442 | |
1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1dr2 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1dyj | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1j39 | UPG | DNA beta-glucosyltransferase | / | 0.441 | |
1qkn | RAL | Estrogen receptor beta | / | 0.441 | |
1z95 | 198 | Androgen receptor | / | 0.441 | |
2cd8 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.441 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2jjj | 0QS | Endothiapepsin | 3.4.23.22 | 0.441 | |
3mnr | SD1 | Heat shock protein HSP 90-alpha | / | 0.441 | |
3q9w | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1b87 | ACO | Aac(6')-Ii protein | / | 0.440 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.440 | |
1dyi | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.440 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.440 | |
2g1p | SAH | DNA adenine methylase | 2.1.1.72 | 0.440 | |
2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
3ch6 | 311 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
3ha5 | SFG | Hydroxymycolate synthase MmaA4 | 2.1.1 | 0.440 | |
3uxh | UXH | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.440 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.440 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.440 | |
4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4gdy | 0X1 | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.440 | |
4o71 | CPB | Bromodomain-containing protein 4 | / | 0.440 | |
4y57 | F63 | Endothiapepsin | 3.4.23.22 | 0.440 | |
4yek | THM | Thymidine phosphorylase | / | 0.440 |